HealthWell: Myelodysplastic Syndromes- Medicare Access

Not Funded
About
The HealthWell: Myelodysplastic Syndromes- Medicare Access program offers vital support for individuals undergoing treatment for Myelodysplastic Syndromes. Participants benefiting from Medicare can access a range of drug products including Aranesp, Epogen, and Gleevec among others. This program facilitates financial assistance through copay and premium reimbursements, ensuring that eligible patients can afford their treatment without income barriers. Re-enrollment is streamlined through the enhanced Patient Portal, making the HealthWell program an essential resource for eligible patients seeking sustainable healthcare solutions.
Insurance requirements: Medicare / Medicaid
Enrollment Forms
Enrollment Form
Benefits
$10000 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Please note that this copay/premium fund may cover offlabel drugs
No Minimum copay reimbursement amount and No Minimum premium reimbursement amount
Eligible patients can complete the application process online or by phone
Patients must submit the Diagnosis Verification form (completed & signed by provider), copy of insurance cards, and prescription cards through the portal or by fax (18002827692) within 30 days of application
Approved patients will receive a letter detailing assistance. They can access their grant by using their ‘HealthWell Foundation Copayment Assistance Card’, by asking their provider’s office or pharmacy to direct bill with HealthWell, or by paying up front and submitting claim to HealthWell for direct reimbursement
Patients will have one full year to use the grant before needing to reenroll (Grants are given on a firstcome, firstserved basis)
For grants to remain active, the first complete reimbursement request must be received within 90 days of approval date, and continue at least every 90 days
Grants with no activity for over 90 days will be considered inactive and closed
Patients who are approved for a grant but do not use a portion of their grant money may not be able to reenroll
Other Programs

CancerCare: Chemotherapy Induced Neutropenia

Medicare / Medicaid

CancerCare: Myelodysplastic Syndromes

Commercially Insured
Medicare / Medicaid
Max Saving: $10000/year*